TGTX ▼ -0.7% - TG Therapeutics, Inc.
$TGTX - TG Therapeutics Announces Publication of Five-Year Comparative Analysis of BRIUMVI Versus Ocrelizumab and Ofatumumab in Relapsing Multiple Sclerosis
12-OCT-2026 07:33 AM ET
Share this post
More filings for $TGTX
View full $TGTX filing history →💬 Comments
Loading comments…
Leave a comment
